![](/img/cover-not-exists.png)
Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease – modelling outcomes in active luminal and fistulizing disease in adults
J. LINDSAY, Y. S. PUNEKAR, J. MORRIS, G. CHUNG-FAYEVolume:
28
Year:
2008
Language:
english
Pages:
12
DOI:
10.1111/j.1365-2036.2008.03709.x
File:
PDF, 217 KB
english, 2008